Patents by Inventor Michael Graeber

Michael Graeber has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphtoic acid for the treatment of dermatological disorders
    Patent number: 7834060
    Abstract: Dermatological disorders having an inflammatory or proliferative component are treated with pharmaceutical compositions containing on the order of 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthanoic acid (adapalene) or salt thereof, formulated into pharmaceutically acceptable media therefor, advantageously topically applicable gels, creams or lotions.
    Type: Grant
    Filed: May 7, 2009
    Date of Patent: November 16, 2010
    Assignee: Galderma Research & Development
    Inventors: Michael Graeber, Janusz Czernielewski
  • METHOD FOR THE TREATMENT OF ACNE USING COMPOSITIONS COMPRISING 0.3% BY WEIGHT OF 6-[3-(1-ADAMANTYL)-4-METHOXYPHENYL]-2-NAPHTHOIC ACID
    Publication number: 20100273882
    Abstract: Dermatological disorders having an inflammatory or proliferative component, notably common acne, are treated with topically applicable pharmaceutical compositions containing about 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthanoic acid (adapalene) or salt thereof, formulated into pharmaceutically acceptable media therefor, advantageously formulated into topically applicable gels, preferably aqueous gels, creams, lotions or solutions.
    Type: Application
    Filed: May 3, 2010
    Publication date: October 28, 2010
    Applicant: Galderma Research & Development
    Inventors: Michael GRAEBER, Janusz Czernielewski
  • Pharmaceutical compositions comprising 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
    Patent number: 7737181
    Abstract: Dermatological disorders having an inflammatory or proliferative component, notably common acne, are treated with topically applicable pharmaceutical compositions containing about 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthanoic acid (adapalene) or salt thereof, formulated into pharmaceutically acceptable media therefor, advantageously formulated into topically applicable gels, preferably aqueous gels, creams, lotions or solutions.
    Type: Grant
    Filed: July 28, 2006
    Date of Patent: June 15, 2010
    Assignee: Galderma Research & Development
    Inventors: Michael Graeber, Janusz Czernielewski
  • Topical application of adapalene for the long-term treatment of acne vulgaris
    Publication number: 20100069495
    Abstract: Administration of adapalene in a topical medicament to a patient so as to sustain its biological response in the treatment of acne vulgaris, wherein the administration pattern of the topical medicament comprises topically applying onto the afflicted skin area a therapeutically effective amount of adapalene at least once every two days for at least 6 months.
    Type: Application
    Filed: November 17, 2009
    Publication date: March 18, 2010
    Applicant: Galderma Research & Development
    Inventor: Michael Graeber
  • Administration of adapalene and benzoyl peroxide for the long-term treatment of acne vulgaris
    Publication number: 20100029762
    Abstract: A regimen for the safe and effective long-term treatment of acne vulgaris entails topically applying onto the affected skin area of a subject afflicted therewith, for a period of time of at least four (4) months, e.g., for at least twelve (12) months and advantageously on a daily basis and preferably once a day, a thus effective amount of a topical medicament containing adapalene and benzoyl peroxide, formulated into a pharmaceutically acceptable medium therefor.
    Type: Application
    Filed: July 29, 2009
    Publication date: February 4, 2010
    Inventors: Michael Graeber, Yin Liu, Barbara Gore
  • Topical application of adapalene for the long-term treatment of acne vulgaris
    Patent number: 7642288
    Abstract: Administration of adapalene in a topical medicament to a patient so as to sustain its biological response in the treatment of acne vulgaris, wherein the administration pattern of the topical medicament comprises topically applying onto the afflicted skin area a therapeutically effective amount of adapalene at least once every two days for at least 6 months.
    Type: Grant
    Filed: July 26, 2007
    Date of Patent: January 5, 2010
    Assignee: Galderma Research & Development
    Inventor: Michael Graeber
  • Online protocol/tool for evaluating acne lesions
    Publication number: 20090305209
    Abstract: A web-based protocol/tool to improve the identification and characterization process of evaluators in recognizing and distinguishing acne lesions, included at least the following program activities: a protocol for a global assessment of acne lesions; a protocol for a lesion counting training; a protocol for a model counting practice.
    Type: Application
    Filed: December 9, 2008
    Publication date: December 10, 2009
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Michael Graeber, Ming Lu, Judi Gidner
  • ADMINISTRATION OF 6-[3-(1-ADAMANTYL)-4-METHOXYPHENYL]-2-NAPHTOIC ACID FOR THE TREATMENT OF DERMATOLOGICAL DISORDERS
    Publication number: 20090281188
    Abstract: Dermatological disorders having an inflammatory or proliferative component are treated with pharmaceutical compositions containing on the order of 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthanoic acid (adapalene) or salt thereof, formulated into pharmaceutically acceptable media therefor, advantageously topically applicable gels, creams or lotions.
    Type: Application
    Filed: May 7, 2009
    Publication date: November 12, 2009
    Applicant: Galderma Research & Development
    Inventors: Michael GRAEBER, Janusz Czernielewski
  • Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
    Patent number: 7579377
    Abstract: Dermatological disorders having an inflammatory or proliferative component are treated with pharmaceutical compositions containing on the order of 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthanoic acid (adapalene) or salt thereof, formulated into pharmaceutically acceptable media therefore, advantageously topically applicable gels, creams or lotions.
    Type: Grant
    Filed: September 10, 2004
    Date of Patent: August 25, 2009
    Assignee: Galderma Research & Development
    Inventors: Michael Graeber, Janusz Czernielewski
  • ADMINISTRATION OF 6-[3-(1-ADAMANTYL)-4-METHOXYPHENYL]-2-NAPHTHOIC ACID FOR THE TREATMENT OF DERMATOLOGICAL DISORDERS
    Publication number: 20080293817
    Abstract: Dermatological disorders having an inflammatory or proliferative component are treated with pharmaceutical compositions containing on the order of 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthanoic acid (adapalene) or salt thereof, formulated into pharmaceutically acceptable media therefor, advantageously topically applicable gels, creams or lotions.
    Type: Application
    Filed: April 15, 2008
    Publication date: November 27, 2008
    Applicant: GALDERMA RESEARCH & DEVELOPMENT, S.N.C.
    Inventors: Michael GRAEBER, Janusz CZERNIELEWSKI
  • Topical application of adapalene for the long-term treatment of acne vulgaris
    Publication number: 20080064755
    Abstract: Administration of adapalene in a topical medicament to a patient so as to sustain its biological response in the treatment of acne vulgaris, wherein the administration pattern of the topical medicament comprises topically applying onto the afflicted skin area a therapeutically effective amount of adapalene at least once every two days for at least 6 months.
    Type: Application
    Filed: July 26, 2007
    Publication date: March 13, 2008
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventor: Michael Graeber
  • Pharmaceutical compositions comprising 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
    Publication number: 20070043119
    Abstract: Dermatological disorders having an inflammatory or proliferative component, notably common acne, are treated with topically applicable pharmaceutical compositions containing about 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthanoic acid (adapalene) or salt thereof, formulated into pharmaceutically acceptable media therefor, advantageously formulated into topically applicable gels, preferably aqueous gels, creams, lotions or solutions.
    Type: Application
    Filed: July 28, 2006
    Publication date: February 22, 2007
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Michael Graeber, Janusz Czernielewski
  • Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
    Publication number: 20050059740
    Abstract: Dermatological disorders having an inflammatory or proliferative component are treated with pharmaceutical compositions containing on the order of 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthanoic acid (adapalene) or salt thereof, formulated into pharmaceutically acceptable media therefore, advantageously topically applicable gels, creams or lotions.
    Type: Application
    Filed: September 10, 2004
    Publication date: March 17, 2005
    Applicant: GALDERMA RESEARCH & DEVELOPMENT, S.N.C.
    Inventors: Michael Graeber, Janusz Czernielewski